FY2025 · ended Dec 31, 2025 · Revenue $5.94B, +10.5% YoY · Filed Feb 26, 2026
Encompass Health Corporation (EHC) files with the SEC under industry code 8060, Services-Hospitals. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $5.9 billion and net income of $566.2 million. Free cash flow was $439.2 million. As of Sep 30, 2026 it held $76.2 million in cash and investments and $2.8 billion in total debt.
Revenue (TTM)
$6.34B
+9.4% vs year-ago TTM
Net income (TTM)
$644.40M
+19.1% vs year-ago TTM
Operating cash flow (TTM)
$1.30B
+17.6% vs year-ago TTM
Free cash flow (TTM)
$457.20M
+13.6% vs year-ago TTM
EPS (TTM)
$6.39
+21.2% vs year-ago TTM
Dividend per share (TTM)
$0.78
+11.4% vs year-ago TTM
Shares outstanding
99.42M
-1.3% vs prior year
Net cash
$-2.73B
as of Sep 30, 2026
Operating margin
12.4%
FY 2022
Company profile
- Industry
- Services-Hospitals (SIC 8060)
- Listed as
- EHC (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Birmingham, AL
- SEC filer status
- Large accelerated filer
- SEC CIK
- 785161
- Former names
- HEALTHSOUTH CORP (until Dec 12, 2017); HEALTHSOUTH REHABILITATION CORP (until Jun 22, 1994)
Other Services-Hospitals companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $5.9B | $5.4B | $4.8B | $4.3B | $4.0B |
| Operating income | — | — | — | $539.5M | — |
| Net income | $566.2M | $455.7M | $352.0M | $271.0M | $412.2M |
| Diluted EPS | $5.54 | $4.46 | $3.47 | $2.70 | $4.11 |
| Operating cash flow | $1.2B | $1.0B | $850.8M | $705.8M | $715.8M |
| Free cash flow | $439.2M | $360.3M | $267.7M | $141.0M | $191.2M |
| Total assets | $7.1B | $6.5B | $6.1B | $5.6B | $6.9B |
| Total liabilities | $3.8B | $3.7B | $3.8B | $3.8B | $4.5B |
| Stockholders' equity | $2.4B | $2.1B | $1.6B | $1.3B | $1.9B |
| Cash and investments | $72.2M | $85.4M | $69.1M | $21.8M | $49.4M |
| Total debt | $2.7B | $2.7B | $2.9B | $3.0B | $3.5B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Oct 28, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Other events
|
Aug 13, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 1, 2026 | May 29, 2026 |
All 1004 Encompass Health Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.